Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prolia in Chinese Men With Osteoporosis
NCT06332014Phase 4Active, not recruiting
- Sponsor
- Amgen
- Start
- Aug 2024
- Primary completion
- Jan 2027
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of denosumab in osteoporosis, sponsored by Amgen. Started Aug 2024; status: active, not recruiting.
02
Drugs
denosumab
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT06332014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06332014.